Tissue Repair Research

Pentosan Polysulfate (PPS)

FDA-approved product existsRecovery & tissue repairImmune & gut
4.7/10

BioHarmony verdict

Neutral

Pentosan polysulfate (oral Elmiron) is an FDA-approved sulfated polysaccharide drug for interstitial cystitis bladder pain, sometimes used off-label for joints. The benefit is modest and contested while it carries a dose-dependent retinal toxicity, with maculopathy risk reaching about 7-fold above 2,000 grams cumulative, per Tao 2025.

Read full report

What is Pentosan Polysulfate (PPS)?

Pentosan polysulfate is a prescription drug, sold as oral Elmiron for interstitial cystitis bladder pain, and it stands out in the repair world for one reason: it is actually FDA-approved with real trials behind it. It is a semi-synthetic sulfated polysaccharide, heparin-like in how it behaves, and that matters because it means this is a small-molecule-style drug, not a peptide. So even when people stack it for joints next to things like BPC-157 or TB-500, it does not belong in the same mechanism bucket as those peptides.

From the BioHarmony report, reviewed 2026-09-08.

How it is thought to work

Restores the bladder protective coating; in joints acts chondroprotective, anti-inflammatory, and clot-dissolving

Safety watch-outs

  • Any new blur, distortion, dark spots, or trouble reading: stop and see an ophthalmologist promptly, since this can signal pigmentary…
  • Unusual bleeding or bruising, blood in the stool, or black stools: stop and consult a clinician, since the drug is heparin-like.
  • Starting or already taking blood thinners or high-dose NSAIDs: do not combine without a clinician, because bleeding risk stacks.
  • Approaching long cumulative use over years: insist on regular retinal screening, since most maculopathy cases follow high cumulative dose.

Full risk profile in the BioHarmony report.

Dosing as published

No approved-label or study protocol is recorded for Pentosan Polysulfate (PPS) yet.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

US approvalFDA-approved product exists
CompoundingAn approved oral product exists; injectable joint products are not covered by that approval
Last checked2026-07-13
Next review2026-10-11 (overdue, details paused)

Primary sources

Sources are still being reviewed for this compound.

  1. 7.5/10BPC-157Strong recommendRecoveryNot FDA approvedBPC-157 is a 15-amino-acid gastric peptide fragment with consistent preclinical repair data, including a 2025 sports-medicine systematic review of 36 studies with 35…
  2. 7.5/10TB-500 (Thymosin Beta-4 Fragment)Strong recommendRecoveryNot FDA approvedTB-500 is a synthetic LKKTETQ fragment marketed for soft-tissue repair, but most human evidence is on full-length topical thymosin beta-4: Sosne 2023 reported corneal…
  3. 7.4/10Thymosin Alpha-1Strong recommendRecoveryNot FDA approvedThymosin Alpha-1 is a 28-amino-acid thymic peptide with strongest evidence in immune-compromised and hospital-adjacent settings: Cao 2024 pooled 39 acute COPD…
  4. 7.2/10GHK-Cu (Copper Peptide)Strong recommendRecoveryNot FDA approvedGHK-Cu is a human copper-binding tripeptide with the best evidence for topical skin repair and wound healing, including Mulder 1994 diabetic ulcer data showing 98.5%…

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.